Carvedilol and Verapamil interaction

Carvedilol and Verapamil: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Carvedilol (Coreg) label · effective 2026-07-31

Moderate

COREG may be used with caution, however, in patients who do not respond to, or cannot tolerate, other antihypertensive agents.

Warnings and precautionsby drug classView label on DailyMed
Moderate

As with other β-blockers, if COREG is administered with calcium channel blockers of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored.

Drug interactionsby drug classView label on DailyMed
Minor

Verapamil- or diltiazem-type calcium channel blockers may affect ECG and/or blood pressure.

Drug interactionsby drug classView label on DailyMed
Minor

Calcium Channel Blockers Conduction disturbance (rarely with hemodynamic compromise) has been observed when COREG is coadministered with diltiazem.

Drug interactionsby drug classView label on DailyMed

From the Verapamil (Verapamil Hydrochloride) label · effective 2025-03-25

Moderate

Beta blockers: reports of excess bradycardia and AV block, including complete heart block; monitor closely ( 7.4 )

Drug interactionsby drug classView label on DailyMed
Moderate

Beta Blockers Concomitant therapy with beta-adrenergic blockers and verapamil may result in additive negative effects on heart rate, atrioventricular conduction, and/or cardiac contractility.

Drug interactionsby drug classView label on DailyMed
Moderate

Antihypertensive Agents Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta blockers) will usually have an additive effect on lowering blood pressure.

Drug interactionsby drug classView label on DailyMed
Minor

Avoid verapamil in patients with severe left ventricular dysfunction (e.g., ejection fraction less than 30% or moderate to severe symptoms of cardiac failure) and in patients with any degree of ventricular dysfunction if they are receiving a beta-adrenergic blocker [see Drug Interactions ( 7.4 )].

Warnings and precautionsby drug classView label on DailyMed
Minor

The combination of extended-release verapamil and beta-adrenergic blocking agents has not been studied.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.